These findings are very novel, as the current hypothesis accepted by most investigators is that BAF180 is a bona fide tumor suppressor and loss of BAF180 promotes cancer by re-targeting the SWI/SNF complex to a set of cancer-promoting genes that are not normally regulated by the SWI/SNF complex.37 The gene discussed is SMARCA1; the disease is neoplasm.